We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$24.1B
AUM Growth
-$134M
Cap. Flow
-$2.11B
Cap. Flow %
-8.76%
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$157M
2
TMO icon
Thermo Fisher Scientific
TMO
+$135M
3
CRM icon
Salesforce
CRM
+$135M
4
IBM icon
IBM
IBM
+$130M
5
DELL icon
Dell
DELL
+$114M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$313M
2
AAPL icon
Apple
AAPL
+$207M
3
INTC icon
Intel
INTC
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$159M
5
CNC icon
Centene
CNC
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Technology 17.95%
3 Communication Services 13.61%
4 Consumer Discretionary 12.67%
5 Financials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTRN icon
1651
Materion
MTRN
$6.04B
-5,298
Closed -$351K
MTZ icon
1652
MasTec
MTZ
$21.9B
-11,312
Closed -$1.06M
MVIS icon
1653
Microvision
MVIS
$78.9M
-14,634
Closed -$4.07M
MVST icon
1654
Microvast
MVST
$302M
-527,575
Closed -$6.49M
NCMI icon
1655
National CineMedia
NCMI
$378M
-29,032
Closed -$1.34M
NCNO icon
1656
nCino
NCNO
$2.1B
-14,621
Closed -$975K
NDAQ icon
1657
Nasdaq
NDAQ
$52.9B
-46,770
Closed -$2.3M
NFE icon
1658
New Fortress Energy
NFE
$101M
-13,113
Closed -$602K
NNN icon
1659
NNN REIT
NNN
$8.99B
-179,004
Closed -$7.89M
NTR icon
1660
Nutrien
NTR
$30.7B
-88,768
Closed -$4.78M
NTRS icon
1661
Northern Trust
NTRS
$33.9B
-9,251
Closed -$972K
NWSA icon
1662
News Corp Class A
NWSA
$15.4B
-69,042
Closed -$1.76M
OGE icon
1663
OGE Energy
OGE
$9.71B
-48,308
Closed -$1.56M
OGI
1664
Organigram Holdings
OGI
$139M
-64,625
Closed -$895K
OIH icon
1665
VanEck Oil Services ETF
OIH
$1.84B
-115,914
Closed -$22.2M
OM icon
1666
Outset Medical
OM
$90.8M
-2,009
Closed -$1.64M
OMCL icon
1667
Omnicell
OMCL
$1.68B
-13,298
Closed -$1.73M
OMER icon
1668
Omeros
OMER
$959M
-476,969
Closed -$8.49M
ACH
1669
Accendra Health
ACH
$214M
-58,785
Closed -$2.21M
ONTF
1670
DELISTED
ON24
ONTF
-35,566
Closed -$1.73M
OPK icon
1671
Opko Health
OPK
$1.02B
-141,094
Closed -$605K
ORC
1672
Orchid Island Capital
ORC
$1.31B
-30,337
Closed -$912K
ORA icon
1673
Ormat Technologies
ORA
$6.65B
-19,324
Closed -$1.52M
ORGO icon
1674
Organogenesis Holdings
ORGO
$239M
-72,909
Closed -$1.33M
ORLY icon
1675
O'Reilly Automotive
ORLY
$76.3B
-14,625
Closed -$495K

Similar funds

Marshall Wace North America's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.

  • Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
  • Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
  • Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
  • Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
  • Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
  • Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
  • Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.